CTD-Spikevax: List of EMA's Embarrasing Redacted Re-Releases of the EMA Transparency Initiative - Update June 26' on Drug Substance, Nonclinical Overview and Written Summaries

Overriding public interest requires full transparency — EMA should clarify how independent validation is to be achieved with these redacted re-releases